Maxonis
Maxonis is a biotechnology company developing LDP-916 (AGRG), a next-generation regenerative gel for Peripheral Nerve Injury (PNI) and Spinal Cord Injury (SCI). Based on 15+ years of research at Tel Aviv Sourasky Medical Center, LDP-916 uses four FDA-recognized materials to guide axonal regrowth and bridge long nerve gaps. Our mission is to deliver a minimally invasive, scalable, and clinically meaningful solution for true nerve regeneration.
7-day free trial · no credit card
Verified contacts
6
available on Kipplo
LinkedIn employees
11
1 to 10 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 6 verified contacts at Maxonis
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
6 contacts with verified email or phone · masked until revealed.
- MA
Mara Almog
R & d Director · Research & Development
EmailPhone - YN
Yael Nadel
Manager Analytical Development · Information Technology
EmailPhone
Showing 2 of 6 verified contacts
Top roles at Maxonis
4 distinct titles indexed · top 4 shown.
- 1co-founder, cto
- 1manager analytical development
- 1procurement consultant
- 1r & d director
Sign up to unlock all 6 contacts at Maxonis
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 6 verified contacts at Maxonis
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.